AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 31, 2006--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P. Hobbs, will present at the upcoming Rodman & Renshaw Eighth Annual Healthcare Conference. The presentation is scheduled for 9:30 AM (Eastern Time) on Monday, November 6, 2006. The event will be held from November 6-8, 2006 at the New York Palace Hotel in New York.Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of AngioDynamics' web site, www.angiodynamics.com a few minutes prior to start time to download any necessary software. The presentation will be archived for one year.
The conference will feature presentations from more than 290 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding the conference can be obtained at www.rodmanandrenshaw.com.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products. More information is available at www.angiodynamics.com.
CONTACT: AngioDynamics, Inc.
Joe Gerardi, 800-772-6446 x115
http://www.angiodynamics.com/
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz
kgolodetz@lhai.com
212-838-3777
Bruce Voss
bvoss@lhai.com
310-691-7100
SOURCE: AngioDynamics, Inc.